ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
4,967.23
-0.88%
US Tech 100
16,556.80
-2.24%
Dow Jones
37,986.40
0.56%
Brent Oil
86.625
0.00%
Bitcoin
63,756.15
-0.11%
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Tissue Regenix Group Plc (TRX) Quote

Tissue Regenix Group Plc

Tissue Regenix Group Plc (TRX)

TRX Gold Corporation
TRX Gold Corporation
61.50
0.00
(0.00%)
Closed April 19 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
61.50
Bid
61.00
Ask
62.00
Volume
23,744
61.50 Day's Range 61.50
49.00 52 Week Range 71.50
Market Cap
43.403M
Previous Close
61.50
Open
61.50
Last Trade
450
@
61
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
65,893
Shares Outstanding
70,574,468
Dividend Yield
-
PE Ratio
-16.10
Earnings Per Share (EPS)
-0.04
Revenue
24.48M
Net Profit
-2.7M

About Tissue Regenix Group Plc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.tissueregenix.com
Headquarters
Leeds, Gbr
Founded
1970
Tissue Regenix Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker TRX. The last closing price for Tissue Regenix was 61.50p. Over the last year, Tissue Regenix shares have traded in a share price range of 49.00p to 71.50p.

Tissue Regenix currently has 70,574,468 shares outstanding. The market capitalization of Tissue Regenix is £43.40 million. Tissue Regenix has a price to earnings ratio (PE ratio) of -16.10.

TRX Latest News

More News

Tissue Regenix Group PLC Holding(s) in Company

Tissue Regenix Group PLC 05 April 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft...

April 05 2024
RNS Regulatory News

Tissue Regenix annual loss narrows sharply as revenue jumps

Tissue Regenix Group PLC on Tuesday said it was aiming for longer-term growth as it reported a sharp reduction in its ...

March 19 2024
Alliance News

Tissue Regenix Group PLC Final results for the year ended 31 December 2023

Tissue Regenix Group PLC 19 March 2024     Tissue Regenix Group plc ('Tissue Regenix', the 'Group', or the 'Company')   Final results for the year ended 31 December 2023 Annual Report and...

March 19 2024
RNS Regulatory News

Tissue Regenix Group PLC Notice of Results

Tissue Regenix Group PLC 01 March 2024     Tissue Regenix Group plc ('Tissue Regenix', the 'Group', or the 'Company')   Notice of full year results Investor presentation   Tissue Regenix Group...

March 01 2024
RNS Regulatory News

TAKING AIM: European growth at Tissue Regenix a positive development

Cavendish analyst Chris Donnellan believes that moves by Tissue Regenix to expand its operations in Europe are positi ...

February 06 2024
Alliance News

IN BRIEF: Tissue Regenix ships first allograft products order

oup PLC - Leeds, England-based medical devices - First order of its allograft products has been shipped from its third ...

February 06 2024
Alliance News

Tissue Regenix Group PLC First EU shipment & new distributor agreements

Tissue Regenix Group PLC 06 February 2024   Tissue Regenix Group plc ('Tissue Regenix', the 'Company', or the 'Group')   First shipment and sale of allograft products in the EU following HPRA...

February 06 2024
RNS Non-Regulatory

Tissue Regenix Group PLC Holding(s) in Company

Tissue Regenix Group PLC 29 January 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of...

January 29 2024
RNS Regulatory News

TRADING UPDATES: Treatt revenue falls; Secure Trust profit picks up

The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...

January 25 2024
Alliance News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10061.561.559.83730961.09679861DE
4-2-3.1496062992163.563.559.86768561.7205303DE
1246.9565217391357.571.5576589364.42208152DE
26712.844036697254.571.550.54994860.66833068DE
522.54.237288135595971.54935735060.49074223DE
1560061.576341171819956.54023381DE
260-551-89.9591836735612.5637.5282103495663.6409369DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TWGTop Wealth Group Holding Ltd
$ 3.73
(101.62%)
36.52M
CSLRComplete Solaria Inc
$ 0.465319
(75.59%)
16.64M
SHOTWSafety Shot Inc
$ 0.48
(60.00%)
6.71k
EGOXNext e GO NV
$ 0.0515
(43.06%)
333.3M
MNDRMobile health Network Solutions
$ 27.2386
(33.72%)
10.35M
YYAIConnexa Sports Technologies Inc
$ 0.8943
(-57.21%)
13.4M
SBFMSunshine Biopharma Inc
$ 1.77
(-46.69%)
11.9M
GTIGraphjet Technology
$ 6.43
(-33.09%)
95.33k
ISPCiSpecimen Inc
$ 0.2883
(-31.52%)
2.86M
BGLCBioNexus Gene Lab Corporation
$ 0.5998
(-29.32%)
735.88k
EGOXNext e GO NV
$ 0.0515
(43.06%)
333.3M
SQQQProShares UltraPro Short QQQ
$ 12.84
(6.38%)
219.91M
AGBAAGBA Group Holding Ltd
$ 1.255
(21.84%)
128.79M
TQQQProShares UltraPro QQQ
$ 49.48
(-6.20%)
125.4M
SINTSiNtx Technologies Inc
$ 0.0414
(3.50%)
109.94M

Discussion

View Full Feed
Rhodan Rhodan 2 minutes ago
Hey Crash, could you have a more negative position on ths?
TGLO
Deportes Deportes 3 minutes ago
We Won fkgn pos
ENZC
mark5150 mark5150 3 minutes ago
You too and thanks for everything.
CLNV
Zardiw Zardiw 3 minutes ago
israel has been doing hideous things to Palestinians for 70 years......what triggered the jail break on Oct 7 was israel was about to normalize relations with Saudi Arabia.......and Hamas knew that would be the end of them.......so they had no choice.......besides, they were hoping israel's response
janice shell janice shell 3 minutes ago
I think not anymore. But I'm not sure.
frrol frrol 4 minutes ago
Reverse that. And I'm sure you can read well.
AVXL
I-Glow I-Glow 5 minutes ago
There are two patent applications and neither have been granted.

The first is a patent application and it hasn't been granted. Application Number: US17/820,629

Drug patents as I have shown are meaningless without passing FDA approved clinical trials.

They
ENZC
RIOgrande44 RIOgrande44 6 minutes ago
All I hear is you don't want to pay or you can't. I am not not sure, what your saying. Can you clarify.
Natural Trader Natural Trader 6 minutes ago
IRAN AND ISREAL killing gaza people think hard
Thompson Thompson 7 minutes ago
Why is it that most all KTRL projects never really appear to go well? Hum?
KRTL
frrol frrol 7 minutes ago
Don't take it personally.
AVXL
porty porty 7 minutes ago
Wow, lots of commentary today. I’ll wait for the NorthPeak assessment.
TGLO
OMOLIVES OMOLIVES 7 minutes ago
OH....by the way .... I love this song ...

https://www.youtube.com/watch?v=cfU2hCnaD-w

....and I am trying to find this slice of the venue @ Summerfest in Milwaukee, Wisconsin @ circa 2018 ...great riff but I need to hear it entirely ..lol


https:/
flatlander_60048 flatlander_60048 7 minutes ago
I agree with the other comment. CERCLA liability from Landfills, Superfund sites, etc could be as much if not more than the PWS settlement. This liability will take many years to play out and is only worsened by the fact that the new EPA drinking water limits for PFAS are ultra low. This means th
real777mellon real777mellon 7 minutes ago
I am having trouble finding the Classes of each LBHI creditor and the % they have been paid thru LBHI PT 28th distribution It took place 4 April 2024. Do you have anything besides the 28 March 2024 notice I could see the updated classes and their distributions/claims %?
LEHNQ
skydog526 skydog526 8 minutes ago
Let's be clear now. I nailed it again and said halving would be a slow float nothing burger.
BTCUSD
Westcoastplaya Westcoastplaya 8 minutes ago
Too funny. You really are a child
DBMM
Hercules1 Hercules1 8 minutes ago
https://twitter.com/randylus/status/1781413202338664949
WDRP
MarkTrouble MarkTrouble 9 minutes ago
https://www.cnn.com/2024/04/19/markets/trump-media-nasdaq-suspected-market-manipulation/index.html
CRGP
hedge_fun hedge_fun 10 minutes ago
What was the pps 3 weeks ago? How……

bout at the peak of the Torres Rally?

The dilution continues, bro!
SFRX
arizona1 arizona1 10 minutes ago
Do all the children of former presidents still get SS protection? Michael and Ron Reagan?
crescentmotor crescentmotor 11 minutes ago
Anavex YouTube: Noble Capital Markets Healthcare Conference

If I understood Dr. Missling correctly, in today's conference he opened the door with respect to presenting more data from the 2b/III trial in a presentation that could precede the full data release in the peer reviewed artic
AVXL
canthelpit canthelpit 11 minutes ago
GTCH THE GOVERNMENT sales eligability i beleive they are already registered since last year,,,pretty sure thats what i read. I just went page for page top to bottom alot of my d&d was listed in there going back years. This 10k is a good refrence point when looking for names, only the second time
GTCH
janice shell janice shell 12 minutes ago
lol, that's good!
Researchfyi Researchfyi 12 minutes ago
That’s a lot of prototypes too that can generate both revenues and operating costs.

Maybe Demo the Martin guitar and send their 20 sales reps to the companies with the highest product sales first.
LQMT

Your Recent History

LSE
TRX
Tissue Regenix
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved